Sort by
Search results
Ristocetin
The ristocetin reagent is proposed for platelet aggregation tests, as an aid for the detection of von Willebrand disease, von Willebrand factor (vWF) determination, and identification of Bernard-Soulier syndrome.
Lyophilized platelets
Measurement of ristocetin cofactor activity of vWF.
Collagen
Investigation of congenital (e.g., Glanzmann’s thrombasthenia, gray platelet syndrome, storage pool disease) or acquired thrombopathy (e.g., myelodisplasic or myeloproliferative syndrome, Waldenström’s disease, multiple myeloma). Follow-up of patients treated with antiplatelet drugs such as aspirin, thienopyridines, abciximab and other NSAIDs and GPIIb/IIIa inhibitors.
BIOPHEN Normal Plasma (Poolplasma, non-titrated)
Non-titrated quality control human citrated plasma for coagulation assays. Dilution plasma for the assay of lupus anticoagulant (LA) with usual laboratory methods.
BIOPHEN Normal Plasma (Poolplasma, non-titrated)
Non-titrated quality control human citrated plasma for coagulation assays. Dilution plasma for the assay of lupus anticoagulant (LA) with usual laboratory methods.
BIOPHEN Plasminogen LRT
Assay of plasminogen in human plasma for the diagnosis of congenital or acquired plasminogen deficiencies. An abnormal plasminogen activity is an indicator for fibrinolytic troubles.
BIOPHEN Heparin anti-IIa (2-stages) -> SEE NEW REF. 220005
Assay proposed for the measurement of heparin anti-thrombin activity in research applications acc. to Pharmacopoeia.
BIOPHEN Heparin (anti-Xa, 2-stages kit) -> SEE NEW REF. 221005
Assay proposed for the measurement of anti-Xa heparin activity in research applications. This assay meets USP/EP requirements.
BIOPHEN Antithrombin (anti-IIa)
Diagnosis of congenital or acquired antithrombin deficiencies. Measurement of AT activity in biological milieu or purified fractions.
FPA Control - ELISA
Quality control of FPA assay (RK016A).